Are you revising your container closure integrity (CCI) testing strategy? Regulators are paying closer attention to the proper design of robust CCI studies. This webcast will introduce the headspace gas ingress testing approach, a robust detection method of critical leaks. This rapid, non-destructive, analytical measurement can be scientifically validated and is an upgrade to the blue dye test. Topics to be discussed include the following:
Key Learning Objectives:
Who Should Attend:
Parenteral drug packaging engineers and formulation scientists, parenteral manufacturing, sterility quality assurance, regulatory affair scientists, pharma packaging development and manufacturing staff, analytical development etc.